| pubmed-article:15364802 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15364802 | lifeskim:mentions | umls-concept:C0040732 | lld:lifeskim |
| pubmed-article:15364802 | lifeskim:mentions | umls-concept:C0878544 | lld:lifeskim |
| pubmed-article:15364802 | lifeskim:mentions | umls-concept:C1135922 | lld:lifeskim |
| pubmed-article:15364802 | lifeskim:mentions | umls-concept:C0205245 | lld:lifeskim |
| pubmed-article:15364802 | lifeskim:mentions | umls-concept:C0439792 | lld:lifeskim |
| pubmed-article:15364802 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:15364802 | pubmed:dateCreated | 2004-9-21 | lld:pubmed |
| pubmed-article:15364802 | pubmed:abstractText | The benefits of skeletal myoblast (SM) transplantation on infarcted myocardium have been investigated extensively; however, little is known about its effects in nonischemic cardiomyopathy models. To address this issue, we tested SM transplantation in CHF147 Syrian hamsters, a strain characterized by a delta-sarcoglycan deficiency that phenotypically features the human setting of primary dilated cardiomyopathy. | lld:pubmed |
| pubmed-article:15364802 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15364802 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15364802 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:15364802 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15364802 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15364802 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:15364802 | pubmed:issn | 1524-4539 | lld:pubmed |
| pubmed-article:15364802 | pubmed:author | pubmed-author:DubocDenisD | lld:pubmed |
| pubmed-article:15364802 | pubmed:author | pubmed-author:MenaschéPhili... | lld:pubmed |
| pubmed-article:15364802 | pubmed:author | pubmed-author:BrunevalPatri... | lld:pubmed |
| pubmed-article:15364802 | pubmed:author | pubmed-author:DesnosMichelM | lld:pubmed |
| pubmed-article:15364802 | pubmed:author | pubmed-author:BisseryAlvine... | lld:pubmed |
| pubmed-article:15364802 | pubmed:author | pubmed-author:FromesYvesY | lld:pubmed |
| pubmed-article:15364802 | pubmed:author | pubmed-author:VilquinJean-T... | lld:pubmed |
| pubmed-article:15364802 | pubmed:author | pubmed-author:HagègeAlbert... | lld:pubmed |
| pubmed-article:15364802 | pubmed:author | pubmed-author:FiszmanMarcM | lld:pubmed |
| pubmed-article:15364802 | pubmed:author | pubmed-author:PoulyJuliaJ | lld:pubmed |
| pubmed-article:15364802 | pubmed:author | pubmed-author:RoucheAndréeA | lld:pubmed |
| pubmed-article:15364802 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:15364802 | pubmed:day | 21 | lld:pubmed |
| pubmed-article:15364802 | pubmed:volume | 110 | lld:pubmed |
| pubmed-article:15364802 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15364802 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15364802 | pubmed:pagination | 1626-31 | lld:pubmed |
| pubmed-article:15364802 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15364802 | pubmed:meshHeading | pubmed-meshheading:15364802... | lld:pubmed |
| pubmed-article:15364802 | pubmed:meshHeading | pubmed-meshheading:15364802... | lld:pubmed |
| pubmed-article:15364802 | pubmed:meshHeading | pubmed-meshheading:15364802... | lld:pubmed |
| pubmed-article:15364802 | pubmed:meshHeading | pubmed-meshheading:15364802... | lld:pubmed |
| pubmed-article:15364802 | pubmed:meshHeading | pubmed-meshheading:15364802... | lld:pubmed |
| pubmed-article:15364802 | pubmed:meshHeading | pubmed-meshheading:15364802... | lld:pubmed |
| pubmed-article:15364802 | pubmed:meshHeading | pubmed-meshheading:15364802... | lld:pubmed |
| pubmed-article:15364802 | pubmed:meshHeading | pubmed-meshheading:15364802... | lld:pubmed |
| pubmed-article:15364802 | pubmed:meshHeading | pubmed-meshheading:15364802... | lld:pubmed |
| pubmed-article:15364802 | pubmed:meshHeading | pubmed-meshheading:15364802... | lld:pubmed |
| pubmed-article:15364802 | pubmed:meshHeading | pubmed-meshheading:15364802... | lld:pubmed |
| pubmed-article:15364802 | pubmed:meshHeading | pubmed-meshheading:15364802... | lld:pubmed |
| pubmed-article:15364802 | pubmed:meshHeading | pubmed-meshheading:15364802... | lld:pubmed |
| pubmed-article:15364802 | pubmed:meshHeading | pubmed-meshheading:15364802... | lld:pubmed |
| pubmed-article:15364802 | pubmed:meshHeading | pubmed-meshheading:15364802... | lld:pubmed |
| pubmed-article:15364802 | pubmed:meshHeading | pubmed-meshheading:15364802... | lld:pubmed |
| pubmed-article:15364802 | pubmed:meshHeading | pubmed-meshheading:15364802... | lld:pubmed |
| pubmed-article:15364802 | pubmed:meshHeading | pubmed-meshheading:15364802... | lld:pubmed |
| pubmed-article:15364802 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15364802 | pubmed:articleTitle | Does the functional efficacy of skeletal myoblast transplantation extend to nonischemic cardiomyopathy? | lld:pubmed |
| pubmed-article:15364802 | pubmed:affiliation | INSERM U582, Institute of Myology, Groupe Hospitalier Pitié-Salpétrière, 47 Boulevard de l'Hôpital, 75651 Paris Cedex 13, France. j.pouly@myologie.chups.jussieu.fr | lld:pubmed |
| pubmed-article:15364802 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15364802 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:15364802 | pubmed:publicationType | Evaluation Studies | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15364802 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15364802 | lld:pubmed |
